The process for filing ongoing and/or reopening Retiree Drug Subsidy applications is incredibly complex. Below are some Plan Sponsor FAQs to assist them with understanding and navigating the RDS program. Plan Sponsors can also find printer-friendly information on the RDS program on our Documents page.
While these requirements are simple enough in theory, more often than not, each piece is completed by different parties. This means that when the time comes to compile this information, miscommunications and oversights can only be expected. This confusion is only compounded by sometimes conflicting and generally complicated rules and restrictions for each item, which are set by the CMS.
The RDS Center May Deny the Reopening
In the event that the appeal is denied, PDA is committed to warehousing all of the Plan Sponsor’s data, in an auditable format, so that it is readily available in case of a CMS audit. Unfortunately, Medicare decisions on RDS appeals are final and cannot be appealed.
Once the Recalculations for are done, the Plan Sponsor may be in an Over Payment Situation
This may result in the Plan Sponsor having to reimburse the CMS some of the previously collected subsidy net of PDA’s improvements.
While this is unlikely, PDA will submit a cost report prior to the Plan Sponsor filing an appeal. It is the choice of the Plan Sponsor whether or not they would like to pursue the appeal. Alternatively, the Plan Sponsor can notify CMS that it believes there is some degree of overpayment or the Plan Sponsor may simply do nothing. If either of those options is selected, PDA remains committed to warehousing all of the Plan Sponsor’s data, in an auditable format, so that it is readily available in case of a CMS audit.